Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah E Wilson

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|September 23, 2022
Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design StudyHannah Chung, Peter C Austin, Kevin A Brown, et al.
Nature Microbiology|February 8, 2022
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in OntarioSharifa Nasreen, Hannah Chung, Siyi He, et al.
Vaccine|November 23, 2021
Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) studySharifa Nasreen, Jun Wang, Jeffrey C Kwong, et al.
Plos One|August 19, 2024
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) studyJames Wright, Natasha Crowcroft, Elizabeth McLachlan, et al.
Heliyon|March 5, 2024
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infectionZaeema Naveed, Cherry Chu, Mina Tadrous, et al.
The Journal of Infection|June 16, 2026
Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virusVajini N Atukorale, Jeffrey C Kwong, Alejandro Hernandez, et al.
The Journal of Infectious Diseases|July 30, 2025
Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017-2019Sarah A Buchan, Jenna Alessandrini, Samantha S M Drover, et al.
Human Vaccines & Immunotherapeutics|May 30, 2023
Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancyEszter Török, Tavleen Dhinsa, Sheryll Dimanlig-Cruz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 1, 2025
COVID-19 vaccination around the time of conception and risk of placenta-mediated adverse pregnancy outcomesAnnette K Regan, Liam Bruce, Carolina Lavin Venegas, et al.
JAMA|March 24, 2022
Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum OutcomesDeshayne B Fell, Tavleen Dhinsa, Gillian D Alton, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|September 23, 2022
Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design StudyHannah Chung, Peter C Austin, Kevin A Brown, et al.
Nature Microbiology|February 8, 2022
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in OntarioSharifa Nasreen, Hannah Chung, Siyi He, et al.
Vaccine|November 23, 2021
Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) studySharifa Nasreen, Jun Wang, Jeffrey C Kwong, et al.
Plos One|August 19, 2024
Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) studyJames Wright, Natasha Crowcroft, Elizabeth McLachlan, et al.
Heliyon|March 5, 2024
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infectionZaeema Naveed, Cherry Chu, Mina Tadrous, et al.
The Journal of Infection|June 16, 2026
Factors associated with severe health outcomes among community-dwelling older adults hospitalized with respiratory syncytial virusVajini N Atukorale, Jeffrey C Kwong, Alejandro Hernandez, et al.
The Journal of Infectious Diseases|July 30, 2025
Incidence of Respiratory Syncytial Virus-Associated Hospitalization Among Adults in Ontario, Canada, 2017-2019Sarah A Buchan, Jenna Alessandrini, Samantha S M Drover, et al.
Human Vaccines & Immunotherapeutics|May 30, 2023
Temporal trends and determinants of COVID-19 vaccine series initiation after recent pregnancyEszter Török, Tavleen Dhinsa, Sheryll Dimanlig-Cruz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 1, 2025
COVID-19 vaccination around the time of conception and risk of placenta-mediated adverse pregnancy outcomesAnnette K Regan, Liam Bruce, Carolina Lavin Venegas, et al.
JAMA|March 24, 2022
Association of COVID-19 Vaccination in Pregnancy With Adverse Peripartum OutcomesDeshayne B Fell, Tavleen Dhinsa, Gillian D Alton, et al.
Pageof 10